Search

everythinglearnresearchcommunity

for

Search:↓

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

A faulty KLHL24 gene leads to hair loss by damaging hair follicle stem cells.

The study created a mouse model to mimic degenerative diseases for testing tissue repair and new therapies.

The genes OVOL1 and OVOL2 are important for hair growth and may be involved in a type of skin tumor.

PTCH gene mutations contribute to basal cell carcinoma development.

Seven new genetic risk areas for prostate cancer were found.

EGF signaling affects gene expression in skin cells, influencing hair growth and potentially cancer.

Keratoacanthoma comes from hair follicle cells.

Identical twins with a rare KRT 86 gene mutation both have the hair disorder monilethrix.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

LRIG1 is linked to better survival in Merkel cell carcinoma.

Twist1 is crucial for UVB-induced skin cancer development.

Human basal cell carcinomas and squamous cell carcinomas have unique gene expression patterns not fully mirrored in mouse models.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Lower levels of MYLK and CALD1 in bladder cancer and osteosarcoma are linked to worse survival rates.

Sun exposure and genetics increase skin cancer risk from precancerous lesions.

Matrical tumors share a common growth mechanism involving the Wnt pathway and consistent PHLDA1 expression.

WYE-130600 may cause skin thickening and irritation.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Trichilemmal carcinoma shares genetic traits with other skin cancers, suggesting similar treatment options.

A rare genetic deletion in the KRT1 gene causes unique skin symptoms in a family.

K15 is a reliable marker for studying stem cells in dog hair follicle tumors.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

Overexpression of certain genes can shorten hair by disrupting the hair-growth cycle.

Activating certain hair follicle cells could prevent hair loss from cancer treatments.